Marie Bosslett, Assistant Editor

Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Explore what drives male pattern hair loss, its emotional toll, and why new topical antiandrogen clascoterone may boost density while limiting systemic effects.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of September.

Joshua Zeichner, MD, presents phase 3 results showing topical clascoterone 5% stays well tolerated for 12 months and boosts hair density, signaling a new DHT-blocking option.

This review of the latest dermatological studies includes insights on stem cell therapies for skin rejuvenation, smoke exposure in HS, hair loss in pediatric IBD, and more.

Genetic study links higher BMI to looking older, but causality stays unclear; Mendelian randomization flags shared signals and candidate genes needing validation.

Dermatitis-related adverse events vary widely across atopic dermatitis systemic trials, driven by disease fluctuation and reporting differences, informing patient counseling and flare definitions.

New review explores why eczema and ADHD often overlap in youth, highlighting sleep loss, itch-driven inflammation, plus screening and treatment tips.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Merz Aesthetics adds two FDA-approved Belotero HA fillers for midface volume and lip fullness, promising natural movement and long-lasting results.

Are beef tallow balms beneficial for the skin or are they just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

New hair-loss therapies aim to block DHT at follicles, using targeted scalp delivery to reduce systemic side effects and improve male pattern baldness outcomes.

FDA review of BOTOX Cosmetic for masseter prominence signals on-label jawline contouring, trial-backed results, clearer dosing guidance, and safer patient counseling.

Genetic analysis finds smoking unlikely to cause urticaria, suggesting past links reflect confounding. Find out what this means for triggers and patient care.

Fractional carbon dioxide laser targets acne conglobata skin bridges and sinus tracts, delivering marked improvement, quick healing, and no recurrence.

This review of the latest dermatological studies includes insights on AGA and cardiovascular risk, adverse events associated with cutaneous procedures, narrowband-UVB phototherapy for urticaria pigmentosa, and more.

Post hoc RESOLVE analysis shows that patients weighing at least 100 kg experience slower clinical response rates to brodalumab than those under 100 kg, establishing body weight over BMI as a key predictor of treatment timing.

Study tracks teens on isotretinoin, finding stable cognition but modest rises in depression and anxiety symptoms, reinforcing the need for ongoing mental health monitoring.

Real-world cohort research links psoriasis biologics to notably fewer heart attacks and strokes over 10 years, with benefits across drug classes and races.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Are "clean" skin care routines legitimate, or are they just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Joshua Arbesman, MD, explains how tailored sun-safety advice balances melanoma risk, aging goals, and quality of life in all types of patients.

Review guides cosmetic skin care in pregnancy vs breastfeeding, highlighting safer topicals, peels, injectables, and when to defer procedures.

Joshua Arbesman, MD, explains how to promote smarter sun habits, educate on melanoma-risk timelines, ease guilt, and answer sunscreen fears fueled by social media.

New CSU treatments like dupilumab, omalizumab and fast-acting remibrutinib, plus biomarker-driven therapies on the horizon, move beyond antihistamines.

This review of the latest dermatological studies includes insights on adalimumab durability in HS, medicolegal issues in hair transplantation, yellow light and vitamin C for melasma, and more.

CSU links to autoimmune disease and mental health burden; learn from Nicholas Brownstone, MD, on key screening tips, symptom clues, and how it differs from inducible hives.

Dermatology Times is looking back on the top stories in dermatology from the month of August.

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

Explore the top dermatology conferences and meetings happening this month and let us know which ones you'll be attending!